Home / Services / By Technology / Gene Editing Services
Trusted by Leading Research & Pharma Institutions

Gene Editing Services

Accelerate your research with precision gene editing powered by CRISPR-Cas9, TALEN, ZFN, and emerging technologies. From gRNA design to cell line development, we deliver reliable genome engineering solutions for academic and industrial applications.

CRISPR-Cas9 Expertise
Multiple Platforms
Custom Solutions
Learn More

Trusted by leading research and pharmaceutical institutions

MIT
Pfizer
Stanford
Roche
Johns Hopkins
Novartis

Why Choose Our Gene Editing

Multiple editing platforms available
Validated gRNA design algorithms
Expert technical support included
Off-target analysis services

CRISPR-Cas9 Editing

gRNA design, Cas9 delivery, knock-in/knockout

Base & Prime Editing

Precision nucleotide modifications

Cell Line Development

Stable cell line generation

Gene Therapy
200+
Service Overview

Comprehensive Gene Editing Solutions

From single gene knockouts to complex multi-genic modifications, our gene editing services provide researchers with the precision tools needed to advance their biological discoveries.

CRISPR-Cas9

Industry-leading CRISPR-Cas9 editing with optimized gRNA design and delivery systems for high-efficiency genome modifications.

  • Custom gRNA design and synthesis
  • Plasmid and RNP delivery options
  • Knockout and knock-in services

Base & Prime Editing

Next-generation precision editing technologies for single nucleotide modifications without double-strand breaks.

  • Cytosine base editors (CBE)
  • Adenine base editors (ABE)
  • Prime editing for all substitutions

Cell Line Development

End-to-end cell line engineering services from concept to validated clonal cell lines.

  • Stable cell line generation
  • Reporter cell line construction
  • Isogenic cell line creation

TALEN & ZFN

Alternative nuclease platforms for applications requiring specific DNA binding characteristics.

  • Custom TALEN design
  • ZFN pair development
  • Validation and optimization

Off-Target Analysis

Comprehensive off-target profiling to ensure the safety and specificity of your edited cells.

  • GUIDE-seq analysis
  • CIRCLE-seq screening
  • Whole genome sequencing

Screening Services

High-throughput CRISPR screening services for target discovery and functional genomics.

  • Genome-wide sgRNA libraries
  • Custom arrayed screens
  • Bioinformatics support

Ready to Accelerate Your Gene Editing Research?

Our experts are here to help you design the optimal editing strategy for your project.

Our Technology

Advanced Gene Editing Platforms

We employ a comprehensive suite of gene editing technologies to meet the diverse needs of your research projects.

Core Technology

CRISPR-Cas9 Gene Editing

Our CRISPR-Cas9 platform delivers high-efficiency genome editing with validated gRNA design algorithms and optimized delivery systems. We support both standard Cas9 and high-fidelity variants for applications requiring enhanced specificity.

gRNA Design

AI-optimized algorithms for maximum on-target activity

Multi-plex Editing

Simultaneous modification of multiple targets

Large Fragment Insertion

Up to 10 kb knock-in capacity

Conditional Knockout

Cre-lox and FLP-FRT systems

95%+

Editing Efficiency

Single Base

Precision Resolution

Precision Editing

Base & Prime Editing

Our next-generation editing platforms enable precise single-nucleotide modifications without introducing double-strand breaks, dramatically reducing unwanted indels and improving product purity.

Cytosine Base Editors (CBE)

C to T conversions with high efficiency

Adenine Base Editors (ABE)

A to G conversions for all contexts

Prime Editors (PE)

All 12 substitution types without DSB

TALEN Technology

Transcription Activator-Like Effector Nucleases offer an alternative to CRISPR for applications requiring specific DNA binding properties or regulatory considerations.

  • Custom TALEN pair design and assembly
  • Validation in multiple cell types
  • Corporate licensing support

ZFN Technology

Zinc Finger Nucleases provide another validated platform for permanent gene modification, particularly valuable for therapeutic applications.

  • Engineered zinc finger domains
  • Pre-validated target sites
  • Clinical-grade development path
Service Specifications

Technical Specifications

Detailed specifications for our gene editing services to help you plan your experiments.

CRISPR-Cas9 Services

gRNA Length 18-20 nt
Knockout Efficiency Up to 99%
Knock-in Size Up to 10 kb
HDR Efficiency Up to 30%

Supported Cell Types

HEK293

HeLa

CHO

U2OS

HCT116

iPSC

Primary Cells

T Cells

Base Editing Capabilities

CBE Editing Efficiency Up to 80%

Cytosine to Thymine conversions

ABE Editing Efficiency Up to 70%

Adenine to Guanine conversions

PE Editing Efficiency Up to 50%

All 12 transition/transversion types

Indels (Base/Prime) < 1%

Minimal unwanted byproducts

Delivery Methods

Lipofection

Lipid-based transfection reagents

Electroporation

Nucleofection for difficult cell types

Viral Vectors

Lentivirus and AAV for stable expression

RNP Delivery

Pre-assembled Cas9-gRNA complexes

Service Workflow

Our Streamlined Process

From initial consultation to validated results, our integrated workflow ensures efficient and reliable gene editing services.

1

Consultation

Our experts review your project requirements and recommend the optimal editing strategy.

  • Target gene analysis
  • Cell type assessment
  • Strategy recommendation
2

Design & Optimization

AI-optimized gRNA design and construct preparation for maximum editing efficiency.

  • gRNA design
  • Off-target prediction
  • Donor template design
3

Editing & Validation

Expert execution of editing experiments with comprehensive validation analysis.

  • Cell transfection
  • Screening & selection
  • Confirmation analysis
4

Delivery & Support

Complete documentation package and ongoing technical support for your project.

  • Clonal isolation
  • Full documentation
  • Expert consultation
Research Applications

Wide Range of Applications

Our gene editing services support diverse research applications across multiple fields.

Disease Modeling

Create cellular models of genetic diseases to study disease mechanisms and test therapeutic interventions.

Drug Discovery

Generate engineered cell lines for compound screening, target validation, and mechanism of action studies.

Functional Genomics

Systematic gene knockout and knock-in studies to elucidate gene function and regulatory networks.

Therapeutic Development

Engineer cell lines for cell therapy applications including CAR-T and gene therapy vector production.

Protein Engineering

Introduce specific mutations to study protein function, optimize enzyme activity, or create fusion proteins.

Pathway Engineering

Modify multiple genes simultaneously to engineer metabolic pathways for bioproduct synthesis.

Customer Testimonials

Trusted by Researchers Worldwide

See what our customers say about their gene editing service experience.

"The CRISPR knockout service exceeded our expectations. We achieved over 90% editing efficiency in our primary T cells, and the technical team was incredibly helpful throughout the project."

Research University

Metabolic Engineering Lab

"We needed a complex double knock-in for our drug discovery project. The team delivered validated clones with both insertions working perfectly. Exceptional service!"

Pharmaceutical Company

Drug Discovery

"The base editing service allowed us to create precise point mutations that would have been impossible with traditional CRISPR. The purity of our edited cell pools was remarkable."

Biotech Company

Research Lab

Scientific Literature

Supported by Peer-Reviewed Research

Our services are built on a foundation of rigorous scientific research and validated methodologies.

CRISPR-based genome editing in disease treatment

Qin H, Xu W, Yao K. Trends in Molecular Medicine. 2023

Comprehensive review of CRISPR-Cas gene editing technologies for therapeutic applications, covering base editing and prime editing advances.

View Publication

Therapeutic Applications of the CRISPR-Cas System

Kang K, Song Y, Kim I, Kim TJ. Bioengineering. 2022

Review focusing on medical applications of CRISPR, including therapeutics for genetic diseases, oncology, and infectious disease.

View Publication

Clinical trials and preclinical applications of CRISPR/Cas

Çerçi B, Uzay IA, Kara MK, Dinçer P. Life Sciences. 2023

Analysis of clinical trials evaluating CRISPR/Cas systems for treating genetic diseases and promising preclinical research.

View Publication

New advances in CRISPR/Cas-mediated precise gene-editing

Richardson C et al. Disease Models & Mechanisms. 2023

Overview of recent progress in optimizing precise genome editing methods and their potential for generating disease models.

View Publication

Genome engineering with targetable nucleases

Carroll D. Annual Review of Biochemistry. 2014

Classic review of ZFN, TALEN, and CRISPR-Cas gene editing technologies and their comparative analysis.

View Publication

Genome editing with CRISPR-Cas nucleases and base editors

Anzalone AV et al. Nature Biotechnology. 2020

Comprehensive review of CRISPR-Cas nucleases, base editors, transposases, and prime editors for genome editing.

View Publication
FAQ

Frequently Asked Questions

Find answers to common questions about our gene editing services.

What types of cells can you edit with CRISPR-Cas9?
We support a wide range of cell types including HEK293, HeLa, CHO, HCT116, U2OS, iPSCs, primary cells, and T cells. Our team will assess your specific cell type and recommend the optimal delivery method and editing strategy.
How do you ensure low off-target effects?
We employ multiple strategies to minimize off-target effects including: AI-optimized gRNA design with high specificity scores, high-fidelity Cas9 variants, RNP delivery for transient expression, and comprehensive off-target analysis using GUIDE-seq, CIRCLE-seq, or whole genome sequencing.
What is the difference between knock-out and knock-in?
Knock-out involves disrupting a gene to prevent its expression, typically through NHEJ-mediated indels. Knock-in involves precisely inserting a DNA sequence at a specific location using HDR with a donor template. Knock-in is more complex and typically has lower efficiency than knock-out.
When should I use base editing vs prime editing?
Base editing is ideal for C-to-T or A-to-G conversions and offers high efficiency with minimal indels. Prime editing can make all 12 types of substitutions plus small insertions and deletions without double-strand breaks, but typically has lower efficiency than base editing. Our team will recommend the best approach based on your specific edit requirements.
What delivery methods do you offer?
We offer multiple delivery methods including lipofection (lipid-based transfection), electroporation/nucleofection (optimized for difficult cell types), viral vectors (lentivirus and AAV for stable expression), and RNP delivery (pre-assembled Cas9-gRNA complexes for enhanced specificity).
How do you validate edited cell pools?
We use multiple validation methods including Surveyor/T7E1 assay for indel detection, Sanger sequencing for confirmation, next-generation sequencing for detailed analysis, and flow cytometry for cell population assessment. Custom validation requirements can be accommodated.
Can you provide clonal cell lines?
Yes, we offer clonal cell line generation as part of our cell line development services. This includes single-cell cloning, expansion, and validation to ensure monoclonality. We use validated workflows to generate high-quality clonal lines with documented stability.
What is your quality control process?
Our quality control includes: initial editing efficiency validation, off-target screening, sequence confirmation of desired edits, mycoplasma testing, sterility testing, and genetic stability assessment. All services include comprehensive documentation for regulatory compliance.

Ready to Start Your Project?

Get a customized quote for your Gene Editing Services project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation